NOXOPHARM LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.068 AUD | +1.49% |
|
+6.25% | -4.23% |
| 04-04 | Noxopharm Receives AU$100,000 to Progress Brain Cancer Drug | MT |
| 02-27 | Noxopharm Narrows Fiscal H1 Net Loss Despite Lower R&D Tax Incentive | MT |
Quotes 5-day view
Delayed Quote Australian S.E.| 26/04/2024 | 29/04/2024 | 30/04/2024 | 01/05/2024 | |
|---|---|---|---|---|
| Last | 0.064 $ | 0.066 $ | 0.067 $ | 0.068 $ |
| Volume | 59 631 | 19 895 | 49 289 | 79 699 |
| Change | +4.92% | +3.13% | +1.52% | +1.49% |
| Opening | 0.06 | 0.07 | 0.07 | 0.07 |
| High | 0.06 | 0.07 | 0.07 | 0.07 |
| Low | 0.06 | 0.07 | 0.07 | 0.07 |
Performance
| 1 day | +1.49% | ||
| 1 week | +6.25% | ||
| Current month | +1.49% | ||
| 1 month | +4.62% | ||
| 3 months | +3.03% | ||
| 6 months | -32.00% | ||
| Current year | -4.23% | ||
| 1 year | +19.30% | ||
| 3 years | -88.67% | ||
| 5 years | -88.28% |
Volumes
marketsDaily volume
79 699
Estimated daily volume
830 751
Avg. Volume 20 sessions
114 507
Daily volume ratio
7.26
Avg. Volume 20 sessions AUD
7 786.48
Avg. Volume 20 sessions USD
5 079.90
Record volume 1
22 861 260
Record volume 2
7 790 463
Record volume 3
7 013 935
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (AUD)
19 489 690
Capitalization (USD)
12 715 074
Net sales (AUD)
6 010 086
Net sales (USD)
3 920 980
Free-Float
64.79 %
Free-Float capitalization (AUD)
12 627 967
Free-Float capitalization (USD)
8 238 486
Average Daily Capital Traded
0.04%
Highs and lows
1 week
0.06
0.07
1 month
0.060.07
Current year
0.050.11
1 year
0.030.17
3 years
0.030.81
5 years
0.030.99
10 years
0.031.80
Indicators
Moving average 5 days
0.07
Moving average 20 days
0.06
Moving average 50 days
0.07
Moving average 100 days
0.07
Price spread / (MMA5)
-3.38%
Price spread / (MMA20)
-5.29%
Price spread / (MMA50)
-0.59%
Price spread / (MMA100)
+5.44%
STIM
RSI 9 days
55.13
RSI 14 days
51.87
Sector Comparison - Biopharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.49% | +6.25% | -4.23% | +19.30% | 12.72M | ||
| -0.17% | -1.77% | -4.41% | -9.39% | 86.85B | ||
| +0.77% | -2.62% | +2.76% | -.--% | 40.16B | ||
| +0.61% | +7.00% | -16.48% | -30.53% | 31.28B | ||
| +0.81% | +2.09% | +57.86% | +47.54% | 25.27B | ||
| +3.18% | -8.63% | -13.58% | -14.08% | 15.33B | ||
| -0.32% | +2.61% | -9.12% | -8.90% | 11.96B | ||
| -1.68% | -12.71% | -42.56% | -35.29% | 11.61B | ||
| +0.71% | +8.60% | +6.89% | +14.43% | 8.83B | ||
| -3.77% | +12.67% | -10.53% | +2.14% | 7.94B | ||
| +1.28% | -0.53% | +1.55% | +15.15% | 7.58B | ||
| +0.23% | +6.37% | +79.59% | +306.67% | 6.77B | ||
| -0.28% | +1.70% | -10.25% | +9.28% | 6.59B | ||
| +1.48% | -0.59% | -7.01% | +7.35% | 6.55B | ||
| +2.32% | +5.11% | -44.06% | -7.23% | 5.55B | ||
| +4.21% | -7.77% | -23.07% | -44.46% | 5.36B | ||
| Average | +0.68% | +1.39% | -2.29% | +17.00% | ||
| Weighted average by Cap. | +0.40% | +0.71% | -0.32% | +3.12% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -4.23% | ||
| 2023 | -51.03% | ||
| 2022 | -62.82% | ||
| 2021 | -20.41% | ||
| 2020 | +75.00% | ||
| 2019 | -33.33% | ||
| 2018 | -62.83% | ||
| 2017 | +169.05% | ||
| 2016 | +127.03% |
- Stock Market
- Equities
- NOX Stock
- Quotes Noxopharm Limited
